Q4 2021 13F Holders as of 12/31/2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
1.24B
-
Number of holders
-
1644
-
Total 13F shares, excl. options
-
1.01B
-
Shares change
-
+5.44M
-
Total reported value, excl. options
-
$73B
-
Value change
-
+$423M
-
Put/Call ratio
-
1.18
-
Number of buys
-
741
-
Number of sells
-
-681
-
Price
-
$72.61
Significant Holders of GILEAD SCIENCES, INC. - Common Stock (GILD) as of Q4 2021
1,844 filings reported holding GILD - GILEAD SCIENCES, INC. - Common Stock as of Q4 2021.
GILEAD SCIENCES, INC. - Common Stock (GILD) has 1,644 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.01B shares
of 1.24B outstanding shares and own 81% of the company stock.
Largest 10 shareholders include BlackRock Inc. (119M shares), Capital Research Global Investors (107M shares), VANGUARD GROUP INC (106M shares), STATE STREET CORP (57.4M shares), Capital World Investors (42.7M shares), Dodge & Cox (37.2M shares), Capital International Investors (36.3M shares), GEODE CAPITAL MANAGEMENT, LLC (22.7M shares), MORGAN STANLEY (15.6M shares), and NORTHERN TRUST CORP (14.5M shares).
This table shows the top 1644 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.